ReWalk Robotics Ltd.

LFWD

IL0011331076

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 02:00:01 17/07/2024 am IST			5-day change	1st Jan Change
3.93 ^USD	+0.77%		+2.88%	-27.81%

03/07	ReWalk Robotics Chairman to Retire, Successor Named	MT
02/07	ReWalk Robotics Ltd. Announces the Retirement of Jeff Dykan as Chairman	CI

ReWalk Robotics Ltd. Provides Revenue Guidance for the Fiscal Year Ended December 31, 2018

January 14, 2019 at 05:30 pm IST

ReWalk Robotics Ltd. provided revenue guidance for the fiscal year ended December 31, 2018. The Company expects that total revenue for the year will be approximately $6.5 million.

Latest news about ReWalk Robotics Ltd.

ReWalk Robotics Chairman to Retire, Successor Named	03/07	MT
ReWalk Robotics Ltd. Announces the Retirement of Jeff Dykan as Chairman	03/07	CI
ReWalk Robotics Ltd. Unveils Newest Addition to Its AlterG Anti-Gravity Product Line - Introducing AlterG Neo	26/06	CI
HC Wainwright Adjusts Price Target on ReWalk Robotics to $13 From $9, Maintains Buy Rating	16/05	MT
Transcript : ReWalk Robotics Ltd., Q1 2024 Earnings Call, May 15, 2024	15/05
Earnings Flash (LFWD) REWALK ROBOTICS (DBA LIFEWARD) Reports Q1 Adjusted Loss $-0.62, vs. Street Est of Adjusted EPS $-0.70	15/05	MT
Earnings Flash (LFWD) REWALK ROBOTICS (DBA LIFEWARD) Reports Q1 Revenue $5.3M, vs. Street Est of $5.6M	15/05	MT
ReWalk Robotics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05	CI
ReWalk Robotics Ltd. Provides Financial Guidance for the Second Quarter and Full Year of 2024	15/05	CI
ReWalk Robotics Ltd. Appoints Mike Swinford to the Board of Directors	19/04	CI
Lifeward, CMS Working to Finalize Exoskeleton Medicare Payment Rate, CEO Says	02/04	MT
ReWalk Robotics Set to Complete 1-for-7 Reverse Split of Ordinary Stock	13/03	MT
ReWalk Robotics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02	CI
Transcript : ReWalk Robotics Ltd., Q4 2023 Earnings Call, Feb 27, 2024	27/02
Rewalk Robotics Ltd. Provides Earnings Guidance for the Full Year and First Quarter of 2024	27/02	CI
Earnings Flash (LFWD) REWALK ROBOTICS Reports Q4 Revenue $6.9M	27/02	MT
ReWalk Robotics Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02	CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) added to NASDAQ Composite Index	30/01	CI
ReWalk Robotics Ltd. will Change its Name to Lifeward	30/01	CI
ReWalk Robotics Ltd. will Change its Ticker to LFWD from RWLK	30/01	CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) dropped from NASDAQ Composite Index	29/01	CI
ReWalk Robotics Expands Direct Sales to Canada; Shares Rise	12/01	MT
ReWalk Robotics Says It Successfully Demonstrates Exoskeleton Prototype	28/11	MT
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype	28/11	CI
ReWalk Robotics Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI

ReWalk Robotics Ltd. doing business as Lifeward is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.

Sector

Medical Equipment, Supplies & Distribution

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for ReWalk Robotics Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.93 USD

Average target price

10.75 USD

Spread / Average Target

+173.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
REWALK ROBOTICS LTD.	-27.81%	33.81M
STRAUMANN HOLDING AG	-16.56%	20.48B
SONOVA HOLDING AG	-3.02%	18.05B
COCHLEAR LIMITED	+13.01%	14.7B
EMBLA MEDICAL HF.	+5.65%	1.78B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-31.27%	1.71B
ANGELALIGN TECHNOLOGY INC.	-0.18%	1.23B
MODERN DENTAL GROUP LIMITED	-3.95%	489M
ANGEL ROBOTICS CO., LTD.	0.00%	331M
DELCATH SYSTEMS, INC.	+91.59%	221M

Medical Prosthetics